{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:34:36Z","timestamp":1770453276651,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research projects in the healthcare industry in Gansu Province","award":["GSWSQN2023-03"],"award-info":[{"award-number":["GSWSQN2023-03"]}]},{"name":"Gansu Key Research and Development Program","award":["25YFFA053"],"award-info":[{"award-number":["25YFFA053"]}]},{"name":"Gansu Key Research and Development Program","award":["24YFWA013"],"award-info":[{"award-number":["24YFWA013"]}]},{"name":"Lanzhou Talent Innovation and Entrepreneurship Program","award":["2023-1-30"],"award-info":[{"award-number":["2023-1-30"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05491-0","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:44:24Z","timestamp":1768002264000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of left atrial appendage closure with or without radiofrequency ablation on cardiac remodeling in atrial fibrillation patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Qi","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengyang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiazheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiliang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shougang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"issue":"7","key":"5491_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/heartjnl-2020-317915","volume":"107","author":"X Du","year":"2021","unstructured":"Du X, Guo L, Xia S, Du J, Anderson C, Arima H, Huffman M, Yuan Y, Zheng Y, Wu S, Guang X, Zhou X, Lin H, Cheng X, Dong J, Ma C. Atrial fibrillation Prevalence, awareness and management in a nationwide survey of adults in China. Heart Br Card Soc. 2021;107(7):535\u201341. https:\/\/doi.org\/10.1136\/heartjnl-2020-317915.","journal-title":"Heart Br Card Soc"},{"issue":"31","key":"5491_CR2","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1093\/eurheartj\/ehae373","volume":"45","author":"N Becher","year":"2024","unstructured":"Becher N, Metzner A, Toennis T, Kirchhof P, Schnabel RB. Atrial fibrillation burden: A new outcome predictor and therapeutic target. Eur Heart J. 2024;45(31):2824\u201338. https:\/\/doi.org\/10.1093\/eurheartj\/ehae373.","journal-title":"Eur Heart J"},{"issue":"15","key":"5491_CR3","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1161\/CIRCULATIONAHA.109.932822","volume":"122","author":"EE Smith","year":"2010","unstructured":"Smith EE, Shobha N, Dai D, Olson DM, Reeves MJ, Saver JL, Hernandez AF, Peterson ED, Fonarow GC, Schwamm LH. Risk score for In-Hospital ischemic stroke mortality derived and validated within the get with the Guidelines-Stroke program. Circulation. 2010;122(15):1496\u2013504. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.932822.","journal-title":"Circulation"},{"issue":"12","key":"5491_CR4","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.jcmg.2014.08.009","volume":"7","author":"R Beigel","year":"2014","unstructured":"Beigel R, Wunderlich NC, Ho SY, Arsanjani R, Siegel RJ. The left atrial appendage: Anatomy, Function, and noninvasive evaluation. JACC Cardiovasc Imaging. 2014;7(12):1251\u201365. https:\/\/doi.org\/10.1016\/j.jcmg.2014.08.009.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"5491_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/europace\/euz212","volume":"22","author":"N Karim","year":"2020","unstructured":"Karim N, Ho SY, Nicol E, Li W, Zemrak F, Markides V, Reddy V, Wong T. The left atrial appendage in humans: Structure, Physiology, and Pathogenesis. Eur. Eur. Pacing arrhythm. Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2020;22(1):5\u201318. https:\/\/doi.org\/10.1093\/europace\/euz212.","journal-title":"Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"key":"5491_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijcard.2018.04.034","volume":"268","author":"N Telles-Garcia","year":"2018","unstructured":"Telles-Garcia N, Dahal K, Kocherla C, Lip GYH, Reddy P, Dominic P, Non-Vitamin K. Antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and Meta-Analysis. Int J Cardiol. 2018;268:143\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2018.04.034.","journal-title":"Int J Cardiol"},{"issue":"2","key":"5491_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000535618","volume":"61","author":"RT Junejo","year":"2024","unstructured":"Junejo RT, Gupta D, Snowdon RL, Lip GYH, Fisher JP. Relationship of warfarin and Apixaban with vascular function in patients with atrial fibrillation. J Vasc Res. 2024;61(2):59\u201367. https:\/\/doi.org\/10.1159\/000535618.","journal-title":"J Vasc Res"},{"issue":"5","key":"5491_CR8","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1161\/STROKEAHA.123.045098","volume":"55","author":"R Chiv","year":"2024","unstructured":"Chiv R, Beradid S, Suissa S, Renoux C. Effectiveness and safety of Edoxaban compared with Apixaban in elderly patients with nonvalvular atrial fibrillation: A Real-World Population-Based cohort study. Stroke. 2024;55(5):1161\u201370. https:\/\/doi.org\/10.1161\/STROKEAHA.123.045098.","journal-title":"Stroke"},{"issue":"11","key":"5491_CR9","doi-asserted-by":"publisher","first-page":"CD011373","DOI":"10.1002\/14651858.CD011373.pub2","volume":"11","author":"M Kimachi","year":"2017","unstructured":"Kimachi M, Furukawa TA, Kimachi K, Goto Y, Fukuma S, Fukuhara S. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease. Cochrane Database Syst Rev. 2017;11(11):CD011373. https:\/\/doi.org\/10.1002\/14651858.CD011373.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"5491_CR10","doi-asserted-by":"publisher","first-page":"e005969","DOI":"10.1161\/CIRCOUTCOMES.119.005969","volume":"13","author":"AF Ozaki","year":"2020","unstructured":"Ozaki AF, Choi AS, Le QT, Ko DT, Han JK, Park SS, Jackevicius CA. Real-World adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: A systematic review and Meta-Analysis. Circ Cardiovasc Qual Outcomes. 2020;13(3):e005969. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.119.005969.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"5491_CR11","doi-asserted-by":"publisher","first-page":"e0266658","DOI":"10.1371\/journal.pone.0266658","volume":"17","author":"C Escobar Cervantes","year":"2022","unstructured":"Escobar Cervantes C, Mart\u00ed-Almor J, Cabeza AIP, Bowrin K, Llorac Moix A, Gen\u00eds Giron\u00e8s M, Gasche D, Millier A, Tardu J, Toumi M, Briere J-B. Real-World Cost-Effectiveness analysis of NOACs versus VKA for stroke prevention in Spain. PLoS ONE. 2022;17(4):e0266658. https:\/\/doi.org\/10.1371\/journal.pone.0266658.","journal-title":"PLoS ONE"},{"issue":"9689","key":"5491_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","volume":"374","author":"DR Holmes","year":"2009","unstructured":"Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P. PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised Non-Inferiority trial. Lancet Lond Engl. 2009;374(9689):534\u201342. https:\/\/doi.org\/10.1016\/S0140-6736(09)61343-X.","journal-title":"Lancet Lond Engl"},{"issue":"9","key":"5491_CR13","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.3390\/jcm11092510","volume":"11","author":"L Bergau","year":"2022","unstructured":"Bergau L, Bengel P, Sciacca V, Fink T, Sohns C, Sommer P. Atrial fibrillation and heart failure. J Clin Med. 2022;11(9):2510. https:\/\/doi.org\/10.3390\/jcm11092510.","journal-title":"J Clin Med"},{"issue":"6","key":"5491_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jchf.2019.03.005","volume":"7","author":"MA Carlisle","year":"2019","unstructured":"Carlisle MA, Fudim M, DeVore AD, Piccini JP. Heart failure and atrial Fibrillation, like fire and Fury. JACC Heart Fail. 2019;7(6):447\u201356. https:\/\/doi.org\/10.1016\/j.jchf.2019.03.005.","journal-title":"JACC Heart Fail"},{"key":"5491_CR15","doi-asserted-by":"publisher","unstructured":"Yang J, Liu Y, Feng L, Liu M, You L, Liu Y, Wu J, Zhang G, Geng X, Xie R. Effect of left atrial appendage closure in combination with catheter ablation on left atrial function for persistent atrial fibrillation. Front Cardiovasc Med. 2021;8. https:\/\/doi.org\/10.3389\/fcvm.2021.666465.","DOI":"10.3389\/fcvm.2021.666465"},{"issue":"5","key":"5491_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.5603\/CJ.a2018.0047","volume":"26","author":"QT Phan","year":"2019","unstructured":"Phan QT, Shin S-Y, Cho I-S, Lee W-S, Won H, Sharmin S, Lee D-Y, Kim T-H, Kim C-J, Kim S-W. Impact of left atrial appendage closure on cardiac functional and structural remodeling: A Difference-in-Difference analysis of propensity score matched samples. Cardiol J. 2019;26(5):519\u201328. https:\/\/doi.org\/10.5603\/CJ.a2018.0047.","journal-title":"Cardiol J"},{"issue":"1","key":"5491_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/jcecho.jcecho_42_19","volume":"30","author":"S Ijuin","year":"2020","unstructured":"Ijuin S, Hamadanchi A, Haertel F, Baez L, Schulze PC, Franz M, Moebius-Winkler S. Improvement in left atrial strain among patients undergoing percutaneous left atrial appendage closure. J Cardiovasc Echography. 2020;30(1):15\u201321. https:\/\/doi.org\/10.4103\/jcecho.jcecho_42_19.","journal-title":"J Cardiovasc Echography"},{"issue":"4","key":"5491_CR18","doi-asserted-by":"publisher","first-page":"e006841","DOI":"10.1161\/CIRCEP.118.006841","volume":"12","author":"LV Boersma","year":"2019","unstructured":"Boersma LV, Ince H, Kische S, Pokushalov E, Schmitz T, Schmidt B, Gori T, Meincke F, Protopopov AV, Betts T, Mazzone P, Foley D, Grygier M, Sievert H, De Potter T, Vireca E, Stein K, Bergmann MW, Nooryani A, Fiedler T, Senatore G, Brigadeau F, Defaye P, Teiger E, Bonnet J-L, Wald C, Szili-Torok T, Tschishow W, Crossland D, Vahanian A, Cruz-Gonzalez I, Thambo J-B, Al Smadi F, Mudra H, Molitoris R, Folkeringa R, Stevenhagen Y, Gras D, Tamburino C, Molon G, Spence M, Infante Oliveira E, Merkulov E, Sukiennik A, Wong T, Busch M, Boldt L-H, Nickenig G, Neef M. Evaluating Real-World clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology: final 2-Year outcome data of the EWOLUTION trial focusing on history of stroke and hemorrhage. Circ Arrhythm Electrophysiol. 2019;12(4):e006841. https:\/\/doi.org\/10.1161\/CIRCEP.118.006841.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"5491_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5603\/KP.a2017.0185","volume":"76","author":"W Streb","year":"2018","unstructured":"Streb W, Mitr\u0119ga K, Szyma\u0142a M, Podolecki T, Kalarus Z. Usefulness of N-Terminal-pro B-Type natriuretic peptide as a heart failure marker in patients undergoing percutaneous left atrial appendage occlusion. Kardiol Pol. 2018;76(1):166\u201372. https:\/\/doi.org\/10.5603\/KP.a2017.0185.","journal-title":"Kardiol Pol"},{"issue":"1","key":"5491_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1161\/01.res.72.1.167","volume":"72","author":"BD Hoit","year":"1993","unstructured":"Hoit BD, Shao Y, Tsai LM, Patel R, Gabel M, Walsh RA. Altered left atrial compliance after atrial Appendectomy. Influence on left atrial and ventricular filling. Circ Res. 1993;72(1):167\u201375. https:\/\/doi.org\/10.1161\/01.res.72.1.167.","journal-title":"Circ Res"},{"issue":"24","key":"5491_CR21","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","volume":"70","author":"VY Reddy","year":"2017","unstructured":"Reddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, Horton RP, Buchbinder M, Neuzil P, Gordon NT, Holmes DR. PREVAIL and PROTECT AF Investigators. 5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017;70(24):2964\u201375. https:\/\/doi.org\/10.1016\/j.jacc.2017.10.021.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"5491_CR22","doi-asserted-by":"publisher","first-page":"e013750","DOI":"10.1161\/CIRCINTERVENTIONS.123.013750","volume":"17","author":"SR Kapadia","year":"2024","unstructured":"Kapadia SR, Yeh RW, Price MJ, Piccini JP, Nair DG, Bansal A, Hsu JC, Freeman JV, Christen T, Allocco DJ, Gibson DN. Outcomes with the WATCHMAN FLX in everyday clinical practice from the NCDR left atrial appendage occlusion registry. Circ Cardiovasc Interv. 2024;17(9):e013750. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.123.013750.","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"5491_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10840-019-00674-0","volume":"58","author":"G Murtaza","year":"2020","unstructured":"Murtaza G, Vuddanda V, Akella K, Della Rocca DG, Sharma S, Li L, Kutty S, Turagam M, Kar S, Holmes D, Lakkireddy D. Impact of left atrial appendage occlusion on left atrial Function\u2014The LAFIT watchman study. J Interv Card Electrophysiol. 2020;58(2):163\u20137. https:\/\/doi.org\/10.1007\/s10840-019-00674-0.","journal-title":"J Interv Card Electrophysiol"},{"issue":"7","key":"5491_CR24","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.hlc.2017.07.001","volume":"27","author":"B Luani","year":"2018","unstructured":"Luani B, Rauwolf T, Groscheck T, Tanev I, Herold J, Isermann B, Schmeisser A, Braun-Dullaeus RC. Serial assessment of natriuretic peptides in patients undergoing interventional closure of the left atrial appendage. Heart Lung Circ. 2018;27(7):828\u201334. https:\/\/doi.org\/10.1016\/j.hlc.2017.07.001.","journal-title":"Heart Lung Circ"},{"issue":"15","key":"5491_CR25","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.3390\/jcm10153443","volume":"10","author":"T Pommier","year":"2021","unstructured":"Pommier T, Leclercq T, Guenancia C, Richard C, Porot G, Laurent G, Lorgis L. Left atrial remodeling and brain natriuretic peptide levels variation after left atrial appendage occlusion. J Clin Med. 2021;10(15):3443. https:\/\/doi.org\/10.3390\/jcm10153443.","journal-title":"J Clin Med"},{"issue":"21","key":"5491_CR26","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","volume":"64","author":"RK Pathak","year":"2014","unstructured":"Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, Alasady M, Hanley L, Antic NA, McEvoy RD, Kalman JM, Abhayaratna WP, Sanders P. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64(21):2222\u201331. https:\/\/doi.org\/10.1016\/j.jacc.2014.09.028.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"5491_CR27","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1253\/circj.68.834","volume":"68","author":"A Fujiki","year":"2004","unstructured":"Fujiki A, Tsuneda T, Sakabe M, Nakagawa K, Mizumaki K, Hirai T, Inoue H. Maintenance of sinus rhythm and recovery of atrial mechanical function after cardioversion with bepridil or in combination with Aprindine in Long-Lasting persistent atrial fibrillation. Circ J Off J Jpn Circ Soc. 2004;68(9):834\u20139. https:\/\/doi.org\/10.1253\/circj.68.834.","journal-title":"Circ J Off J Jpn Circ Soc"},{"key":"5491_CR28","doi-asserted-by":"publisher","unstructured":"Yang J, You L, Liu M, Zhang G, Feng L, Liu Y, Geng X, Wu J, Xie R. Impact of Left Atrial Appendage Closure Combined with Catheter Ablation on Endocrine and Mechanical Cardiac Function in Patients with Atrial Fibrillation. J. Intervent. Cardiol. 2022, 2022, 1\u201310. https:\/\/doi.org\/10.1155\/2022\/3932912","DOI":"10.1155\/2022\/3932912"},{"issue":"13","key":"5491_CR29","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","volume":"392","author":"OM Wazni","year":"2025","unstructured":"Wazni OM, Saliba WI, Nair DG, Marijon E, Schmidt B, Hounshell T, Ebelt H, Skurk C, Oza S, Patel C, Kanagasundram A, Sadhu A, Sundaram S, Osorio J, Mark G, Gupta M, DeLurgio DB, Olson J, Nielsen-Kudsk JE, Boersma LVA, Healey JS, Phillips KP, Asch FM, Wolski K, Roy K, Christen T, Sutton BS, Stein KM, Reddy VY. OPTION trial Investigators. Left atrial appendage closure after ablation for atrial fibrillation. N Engl J Med. 2025;392(13):1277\u201387. https:\/\/doi.org\/10.1056\/NEJMoa2408308.","journal-title":"N Engl J Med"},{"issue":"19","key":"5491_CR30","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","volume":"144","author":"D Lakkireddy","year":"2021","unstructured":"Lakkireddy D, Thaler D, Ellis CR, Swarup V, Sondergaard L, Carroll J, Gold MR, Hermiller J, Diener H-C, Schmidt B, MacDonald L, Mansour M, Maini B, O\u2019Brien L, Windecker S. On behalf of the amulet IDE Investigators. Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (Amulet IDE): A Randomized, controlled trial. Circulation. 2021;144(19):1543\u201352. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.057063.","journal-title":"Circulation"},{"issue":"2","key":"5491_CR31","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.3892\/etm.2018.7086","volume":"17","author":"H Zhang","year":"2019","unstructured":"Zhang H, Tang Z, Han Z, Zeng L, Wang C. Role of real Time\u2013three dimensional transesophageal echocardiography in left atrial appendage closure with LACBES\u00ae devices. Exp Ther Med. 2019;17(2):1456\u201362. https:\/\/doi.org\/10.3892\/etm.2018.7086.","journal-title":"Exp Ther Med"},{"issue":"12","key":"5491_CR32","doi-asserted-by":"publisher","first-page":"450","DOI":"10.31083\/j.rcm2512450","volume":"25","author":"J Zhou","year":"2024","unstructured":"Zhou J, Zhang Z, Zhang K, Zhang T, He Q, Zhang J. Comparative endothelialization of the watchman plug device and LACBES pacifier occluder after left atrial appendage closure. Rev Cardiovasc Med. 2024;25(12):450. https:\/\/doi.org\/10.31083\/j.rcm2512450.","journal-title":"Rev Cardiovasc Med"},{"issue":"1","key":"5491_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12872-024-04383-z","volume":"25","author":"S Zhang","year":"2025","unstructured":"Zhang S, Xiong S, Zhang S, Chen K, Wang H, Li K, Xu X, Zhao X, Zhu N, Huang X, Qin Y, Guo Z, Bai Y. WATCHMAN versus LACbes\u00ae device for percutaneous left atrial appendage closure: A Single-Center, Propensity-Matched study. BMC Cardiovasc Disord. 2025;25(1):18. https:\/\/doi.org\/10.1186\/s12872-024-04383-z.","journal-title":"BMC Cardiovasc Disord"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05491-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05491-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05491-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T15:26:15Z","timestamp":1770391575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-025-05491-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5491"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05491-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Second Hospital of Lanzhou University (Approval No. 2023A-319). Written informed consent was obtained from all patients prior to the procedure, including consent for the use of their anonymized clinical records and follow-up data for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"126"}}